Your ANSwer for Workers' Compensation Medical Cost Containment

Call Us Today!|info@ans-solutions.com
  • Permalink Gallery

    ANS Solutions to Feature 2018 Renewal of the $1 Million Dollar Performance Guarantee Program at the 2017 NWCDC

ANS Solutions to Feature 2018 Renewal of the $1 Million Dollar Performance Guarantee Program at the 2017 NWCDC

ANS Solutions, one of the nation’s leading providers of pharmacy cost containment services in the Workers Compensation industry, will feature the 2018 Renewal of its $1 Million Dollar Performance Guarantee Program at the 2017 NWCDC in Las Vegas Nevada on December 6th, 2017 at BOOTH 2615.

Our program provides Workers Comp payers a guarantee on the life expectancy savings achieved via our “industry unique” pharmacy intervention process.  We assure our clients a $1 Million Dollar Savings per 10 Case Referral as part of a Pilot Program with the Company.  […]

December 4th, 2017|Pharmacotherapy Review|Comments Off on ANS Solutions to Feature 2018 Renewal of the $1 Million Dollar Performance Guarantee Program at the 2017 NWCDC

Opioid Rescue Therapy, Not Just A Quick Fix…

91 Americans lose their lives every day to opioid overdose, according to the Centers for Disease Control and Prevention (CDC).  That is over 33,000 Americans each year, and the rate is only rising, actually having quadrupled since 1999.  It is now accurately categorized as an Epidemic and, appropriately, stringent private and public institutional changes are being implemented to minimize the likelihood of future abuse.  This includes limited pill counts, prescription drug monitoring platforms, closed formularies, etc.  These improvements reduce the likelihood of future dependency, but what about those already […]

November 13th, 2017|Drug Utilization Review, Medical Cost Containment|Comments Off on Opioid Rescue Therapy, Not Just A Quick Fix…

Exorbitant Price Increases in Workers’ Compensation

Sudden and exorbitant drug price increases in recent years have brought the annual cost of treatment for some patients to hundreds of thousands of dollars, and have forced others to go without, sparking outrage throughout the United States.

Price increases involving critical, life-saving drugs like EpiPen® and Daraprim® have been labeled “outrageous”, “predatory”, and “price gouging” events that solely drive drug company profits. The example of Daraprim®, a medication that had been available for 63 years yet had a 5,000% price increase in a single day, was so shocking it […]

October 9th, 2017|Workers Compensation Industry|Comments Off on Exorbitant Price Increases in Workers’ Compensation

Saving Billions with Collaboration

Medical misdiagnoses can happen and a recently released report shows a staggeringly-high incidence of this occuring: As much as one-fifth of claims involve diagnosis errors that are extending the length of time that injured workers are treated and costing the workers’ comp system billions of dollars in the process.

Stunning Numbers

The 10-year study, conducted by Boston medical consultation service, Best Doctors, dicovered that out of an estimated 250,000 workers’ comp injuries,  21% involved misdiagnosis and/or inappropriate medical treatment. In the most expensive top 5% of claims, medical treatment error rates […]

August 29th, 2017|Drug Utilization Review|Comments Off on Saving Billions with Collaboration

Can Technology Help?

State and local governments collect a lot of health data, but as it turns out, there are many roadblocks to putting that data to its highest and best use. Building a bridge, however, could create the potential for its use in battling the U.S. opioid epidemic, which is taking its toll in every corner of the country, across all ages and socioeconomic backgrounds. Just how could digging a little deeper into this data help to uncover the hidden facets of this epidemic?

Mining for Gold

Law enforcement, […]

August 11th, 2017|Workers Compensation Industry|Comments Off on Can Technology Help?
  • drug utilization
    Permalink Gallery

    Government Struggles to Hold Opioid Manufacturers Accountable

Government Struggles to Hold Opioid Manufacturers Accountable

For the first time ever, the U.S. DEA targeted a prescription drug manufacturer for their role in black market opioids and damages incurred. Mallinckrodt Pharmaceuticals, one of the largest national manufacturers of the highly addictive generic painkiller oxycodone, one of the leading drugs responsible for the more than 15,000 overdose deaths in 2015, was accused of shirking its responsibility to report suspicious drug orders.

Who’s to Blame For The Opioid Epidemic?

Created at Mallinckrodt’s Hobart, NY facility, oxycodone shipped via its distributor network, including KeySource, Sunrise Wholesale and Cardinal […]

July 24th, 2017|Clinical Alert, Drug Utilization Review, Pharmaceutical Industry|Comments Off on Government Struggles to Hold Opioid Manufacturers Accountable
  • opioid showdown
    Permalink Gallery

    Opioid Showdown: Can States Surpass Federal & Address Big Pharma?

Opioid Showdown: Can States Surpass Federal & Address Big Pharma?

With some states and areas across the country on the receiving end of opioid painkiller prescription shipments that outnumber the people housed therein, state officials are beginning to address the link between the opioid crisis, Big Pharma, and the heavy burden weighing on their municipalities. In an attempt to hold Big Pharma accountable, they’re taking a page out of past lawsuits against tobacco companies – and suing them.

Key Players
Until now, these multibillion dollar companies have been sidelined in the fight against the opioid epidemic. Now they’re being looked at […]

July 10th, 2017|Pharmacotherapy Review|Comments Off on Opioid Showdown: Can States Surpass Federal & Address Big Pharma?

How Does Doctor Shopping Impact The Opioid Epidemic?

Surprisingly, the non-medical prescription of drugs, including opioids, continues, with only states holding legislation against this dubious practice smothering the flames helping stoke the opioid addiction fire. Since 1999, deaths from prescription opioids have quadrupled, alongside opioid sales of painkillers such as oxycodone (Oxycontin) and hydrocodone (Vicodin). But this hasn’t stopped opioid abusing patients from trying to nab a couple of extra pills by ‘doctor shopping,’ the practice of hopping from physician to physician and playing the numbers until finding a doctor who will meet the patient’s desire for […]

June 26th, 2017|Drug Utilization Review|Comments Off on How Does Doctor Shopping Impact The Opioid Epidemic?

Medical Marijuana Vs. Big Pharma

Increasingly gaining ground as an accepted medicine by top health associations, researchers, and medical journals, the marijuana industry continues its massive expansion, with legalization encompassing more than half the U.S. Predicted to expand nationwide by 2021 by investment firm The Motley Fool, other sectors of the economy are feeling the strain of the industry’s new growth – but no one greater than Big Pharma.

Marijuana & Pharmaceutical Market Share
In an effort to determine how cannabis cash flow is effecting the pharmaceutical industry, researchers at the University of Georgia uncovered just […]

June 14th, 2017|Drug Utilization Review, Pharmaceutical Industry|Comments Off on Medical Marijuana Vs. Big Pharma

Medical Marijuana and the Workers Compensation Conundrum

Because the U.S. Federal Government has dug-in its feet, leaving marijuana as an illegal, Schedule I drug under the Controlled Substances Act, state governments have been left to individually pave their own legalization paths, leaving a frustrated public in the wake. Employers, employees, doctors, workers comp case managers, and more feel frustratingly in-the-dark as ever-diversified, continually evolving legislation continues to change the landscape. This is the first post of our two part series of spotlighting medical marijuana in the marketplace.

What We Do Know About Medical Marijuana

May 31st, 2017|Drug Utilization Review, Medical Cost Containment|Comments Off on Medical Marijuana and the Workers Compensation Conundrum